Interojo Inc. (KOSDAQ:119610)
South Korea · Delayed Price · Currency is KRW 19,440
+340 (1.78%)
Aug 14, 2025, 2:40 PM KST
Interojo Revenue
Interojo had revenue of 23.13B KRW in the quarter ending March 31, 2025, a decrease of -31.24%. This brings the company's revenue in the last twelve months to 105.33B, down -13.45% year-over-year. In the year 2024, Interojo had annual revenue of 115.84B, down -2.90%.
Revenue (ttm)
105.33B
Revenue Growth
-13.45%
P/S Ratio
2.28
Revenue / Employee
149.83M
Employees
703
Market Cap
240.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 115.84B | -3.46B | -2.90% |
| Dec 31, 2023 | 119.30B | 1.48B | 1.25% |
| Dec 31, 2022 | 117.82B | 10.29B | 9.57% |
| Dec 31, 2021 | 107.53B | 19.33B | 21.92% |
| Dec 31, 2020 | 88.20B | -4.37B | -4.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| PharmaResearch | 392.31B |
| Peptron | 4.30B |
| LigaChem Biosciences | 146.42B |